P130010/S005: VEGA Steroid-Eluting Endocardial Leads (VEGA R45, VEGA R52, and VEGA R58)
FDA’s recorded scope: manufacturing process improvements for welding of pacing leads
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 8 FDA records to the applicant name MicroPort CRM S.r.l.. 7 entries are PMA supplements. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jul 23, 2025 to Jan 15, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code NVN appears in 3 of the 8 linked filings. The collection spans 4 FDA product codes and 4 original PMA application families. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P130010, with 3 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: Via Crescentino S.N., Saluggia, 13040. Recorded on P130010/S005, decision dated Jan 15, 2026.
Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes; Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D); Defibrillator, Implantable, Dual-Chamber; Implantable Pacemaker Pulse-Generator.
FDA’s recorded scope: manufacturing process improvements for welding of pacing leads
FDA’s recorded scope: approval for the ENERGYA/TALENTIA family of ICDs and CRT-Ds and associated SmartTouch Programmer software modules, and updates to the Remote Monitoring System.
FDA’s recorded scope: approval for the ENERGYA/TALENTIA family of ICDs and CRT-Ds and associated SmartTouch Programmer software modules, and updates to the Remote Monitoring System.
FDA’s recorded scope: approval for the ENERGYA/TALENTIA family of ICDs and CRT-Ds and associated SmartTouch Programmer software modules, and updates to the Remote Monitoring System.
FDA’s recorded scope: Approval for the addition of Mylar spacers to our ALIZEA/CELEA pacemakers, allow hybrid tab replacements to occur at Microports Saluggia, Italy facility, and changes in manufacturing processes of other MicroPorts pacemaker, ICD, and CRT-D systems.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.